glp-1 obesity drug news today september 15 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 New GLP-1 Pill Foundayo (Orforglipron)
Description
Figure 1: Mechanism of Natural GLP-1 in the Joint Environment Source: Created by Haider et al 2026 Discussion Scientists have made a significant breakthrough in arthritis research through their discovery of GLP-1 activity in joint tissues
Anti-obesity medications and investigational agents: an Obesity Medicine Association (OMA) clinical practice statement (CPS) 2022
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
JAMA Intern Med 2022;182:513-9.ArticlePubMedPMC 40
A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro
Diabetes Ther research Treat Educ Diabetes related Disord
